W. Bara

Effect of Xpert MTB/RIF on clinical outcomes in routine care settings: individual patient data meta-analysis

F. Cobelens, M. Hoelscher, K. Dheda, 2019, The Lancet. Global health.

Xpert(®) MTB/RIF detection of rifampin resistance and time to treatment initiation in Harare, Zimbabwe.

P. Hopewell, P. Mason, J. Metcalfe, 2016, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

Suboptimal specificity of Xpert MTB/RIF among treatment-experienced patients

P. Hopewell, P. Mason, J. Metcalfe, 2015, European Respiratory Journal.

Effect of new tuberculosis diagnostic technologies on community-based intensified case finding: a multicentre randomised controlled trial.

K. Dheda, B. Mayosi, J. Peter, 2017, The Lancet. Infectious diseases.

Mother-to-child transmission of HIV-1 and infant mortality in the first six months of life, in the era of Option B Plus combination antiretroviral therapy.

D. Katzenstein, L. Zijenah, T. Bandason, 2021, International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases.

Drug-Resistant Tuberculosis in High-Risk Groups, Zimbabwe

P. Hopewell, P. Mason, J. Metcalfe, 2014, Emerging infectious diseases.